Arkolith/Insider Trading/IONS/Form 4

Klein Joseph III

DirectorIONIS PHARMACEUTICALS INC (IONS) · full profile →Form 4 · filed May 5, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$743K
Net Open-Market Flow
-$743K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 1, 2026Option exercise(M)10K$47.11$476K21K
May 1, 2026Sell(S)9K$73.35$637K12K
May 1, 2026Sell(S)1K$74.45$107K11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 1, 2026Option exercise(M)10K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000874015-26-000182) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML